Practical Considerations for a Two-Stage Confirmatory Adaptive Clinical Trial Design and Its Implementation: ADVENT Trial

作者: Pravin R. Chaturvedi , Zoran Antonijevic , Cyrus Mehta

DOI: 10.1007/978-1-4939-1100-4_20

关键词:

摘要: In this chapter, we provide the details of an innovative two-stage, seamless adaptive clinical trial called ADVENT. This trial was conducted as a “final phase 3” clinical trial to establish the safety and efficacy of a first-in-class antidiarrheal agent, crofelemer, for the symptomatic relief of diarrhea in HIV patients receiving anti-retroviral therapy. Given that this was a trial with two-stage design that included a dose selection, it was necessary to demonstrate the strong control of Type 1 error. This was accomplished with a close testing procedure applied …

参考文章(16)
Kerstin Bendfeldt, Martin Zeitz, Reiner Ullrich, Anton Josef Kroesen, Jörg Dieter Schulzke, Michael Fromm, Hagen Bode, Gisela Stoltenburg-Didinger, Oliver Holger Kraemer, Luzie Lenzner, The HIV protease inhibitors saquinavir, ritonavir, and nelfinavir induce apoptosis and decrease barrier function in human intestinal epithelial cells. Antiviral Therapy. ,vol. 10, pp. 645- 655 ,(2005)
David Lawrence, Frank Bretz, Stuart Pocock, INHANCE: An Adaptive Confirmatory Study with Dose Selection at Interim Springer Basel. pp. 77- 92 ,(2014) , 10.1007/978-3-0348-0709-8_5
Francisco Martinez-Sandoval, Daniel DiCesare, John J Mathewson, David Ashley, Steven B Porter, James E Pennington, Herbert L DuPont, Herbert L DuPont, A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico The American Journal of Gastroenterology. ,vol. 97, pp. 2585- 2588 ,(2002) , 10.1016/S0002-9270(02)04385-X
Martin Posch, Franz Koenig, Michael Branson, Werner Brannath, Cornelia Dunger-Baldauf, Peter Bauer, Testing and estimation in flexible group sequential designs with adaptive treatment selection. Statistics in Medicine. ,vol. 24, pp. 3697- 3714 ,(2005) , 10.1002/SIM.2389
John Orloff, Frank Douglas, Jose Pinheiro, Susan Levinson, Michael Branson, Pravin Chaturvedi, Ene Ette, Paul Gallo, Gigi Hirsch, Cyrus Mehta, Nitin Patel, Sameer Sabir, Stacy Springs, Donald Stanski, Matthias R. Evers, Edd Fleming, Navjot Singh, Tony Tramontin, Howard Golub, The future of drug development: advancing clinical trial design Nature Reviews Drug Discovery. ,vol. 8, pp. 949- 957 ,(2009) , 10.1038/NRD3025
Aldo AM Lima, Richard L Guerrant, Cirle A Warren, Gerly AC Brito, Reinaldo B Oriá, Jesus E Sevilleja, Bruna MC Oliveira, Jamilly G Maciel, Carolina V Aguiar, Manuel B Braga Neto, None, Evaluation of HIV protease and nucleoside reverse transcriptase inhibitors on proliferation, necrosis, apoptosis in intestinal epithelial cells and electrolyte and water transport and epithelial barrier function in mice BMC Gastroenterology. ,vol. 10, pp. 90- 90 ,(2010) , 10.1186/1471-230X-10-90
Michael Field, Intestinal ion transport and the pathophysiology of diarrhea Journal of Clinical Investigation. ,vol. 111, pp. 931- 943 ,(2003) , 10.1172/JCI18326
Mark Holodniy, Johannes Koch, Mark Mistal, Jamey Maimares Schmidt, Atul Khandwala, James E Pennington, Steven B Porter, A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS The American Journal of Gastroenterology. ,vol. 94, pp. 3267- 3273 ,(1999) , 10.1111/J.1572-0241.1999.01535.X
R. Ubillas, S.D. Jolad, R.C. Bruening, M.R. Kernan, S.R. King, D.F. Sesin, M. Barrett, C.A. Stoddart, T. Flaster, J. Kuo, F. Ayala, E. Meza, M. Castañel, D. Mcmeekin, E. Rozhon, M.S. Tempesta, D. Barnard, J. Huffman, D. Smee, R. Sidwell, K. Soike, A. Brazier, S. Safrin, R. Orlando, P.T.M. Kenny, N. Berova, K. Nakanishi, SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago). Phytomedicine. ,vol. 1, pp. 77- 106 ,(1994) , 10.1016/S0944-7113(11)80026-7